10 likes | 89 Views
L. arm SSM III, 1.18mm. L. axillary LNs Lymphadenectomy 7 N+/17. L. supraclavicular LN MAGE3+++. DTIC x2. APR 01. FEB 95. JUL 01. AUG 01. SEP 01. 1. 16x13 mm………………………...16x12…….…………………….14x12……………………………14x10 mm………………………………..13x13mm
E N D
L. arm SSM III, 1.18mm L. axillary LNs Lymphadenectomy 7 N+/17 L. supraclavicular LN MAGE3+++ DTIC x2 APR 01 FEB 95 JUL 01 AUG 01 SEP 01 1 16x13 mm………………………...16x12…….…………………….14x12……………………………14x10 mm………………………………..13x13mm (necrosis) (necrosis) (necrosis) 14x14 mm………………………….9x7……...……………………...9x7………………………………9 mm…………………………………….9 mm (necrosis) 2 L. supraclavicular 3 10x9 mm…………………………...7x7………...…………...………9x7………………………………8 mm…………………………………….8 mm (necrosis) 9x9 mm………………………..…..4.5………….……………………NA……………………………….NA……….…………………………….10 mm 4 5 5, 4, 3 mm………………………....=……………………………...9 mm………………………...…21x15mm…...……………………………..22 mm OCT 01 NOV 01 DEC 01 JAN 02 FEB 02 MAR 02 APR 02 MAY 02 Cytapheresis Dex production Cytapheresis Immunomonitoring Initiation Continuation 13 mm (2 N+/3) Lymphadenectomy 1 MAGE3 +++ 3 8 mm (N+) 5 15x15 mm (N-) R. cervical (new) 6 12 mm (N+) Stable disease Haloneavi Relapse JUL 02 AUG 02 SEP 02 JUL 03 JUN 02 OCT 03 Surgery Cytapheresis Dex production Retreatment Vaccine discontinuation